Dr. Loghin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Houston, TX 77030Phone+1 832-325-7211Fax+1 713-512-2245
Summary
- Dr. Catalin Loghin is a cardiologist based in Houston, TX, with subspecialties in echocardiography, nuclear cardiology, cardiothoracic imaging, and non-invasive cardiology. He completed his fellowship in cardiovascular disease and residency in internal medicine at the University of Texas Health Science Center at Houston. His expertise includes general cardiology, hypertension, coronary artery disease, echocardiography, and nuclear cardiology. Dr. Loghin has authored several publications in reputable journals, addressing topics like myocardial infarction, valve implantation, and cardiovascular imaging. He was recognized with the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.
Clinical Expertise
- Advanced cardiac imaging, Echocardiography, Nuclear cardiology, General cardiology
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Cardiovascular Disease, 2001 - 2004
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1997 - 1999
- University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1985
Certifications & Licensure
- TX State Medical License 2001 - 2026
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Left internal mammary artery to great cardiac vein fistula: innocent bystander or guilty as charged?Katia Bravo-Jaimes, Catalin Loghin, Salman Arain, Nils P. Johnson
Coronary Artery Disease. 2021-06-01 - 84 citationsA Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN...Roberto Bolli, Raul D. Mitrani, Joshua M. Hare, Carl J. Pepine, Emerson C. Perin
European Journal of Heart Failure. 2021-04-01 - 30 citationsAllogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Roberto Bolli, Emerson C. Perin, Emerson C. Perin, James T. Willerson
JACC. Cardiooncology. 2020-11-01
Press Mentions
- Transcatheter Heart Valve Handbook: A Surgeons' and Interventional Council ReviewDecember 7th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: